

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.82258017 |
| 2 | sarcomere organization (GO:0045214) | 5.18996236 |
| 3 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.18136095 |
| 4 | plasma membrane repair (GO:0001778) | 5.14101324 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.06227335 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.00149745 |
| 7 | cardiac myofibril assembly (GO:0055003) | 4.94440627 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 4.80782066 |
| 9 | myofibril assembly (GO:0030239) | 4.80382835 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.77016024 |
| 11 | muscle filament sliding (GO:0030049) | 4.72279253 |
| 12 | actin-myosin filament sliding (GO:0033275) | 4.72279253 |
| 13 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.69268433 |
| 14 | regulation of cell communication by electrical coupling (GO:0010649) | 4.44539596 |
| 15 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.41322687 |
| 16 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.17295670 |
| 17 | cardiac muscle contraction (GO:0060048) | 4.14202770 |
| 18 | actin-mediated cell contraction (GO:0070252) | 4.07022309 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.02421384 |
| 20 | regulation of relaxation of muscle (GO:1901077) | 3.83343822 |
| 21 | cell communication involved in cardiac conduction (GO:0086065) | 3.77998544 |
| 22 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.77910570 |
| 23 | macroautophagy (GO:0016236) | 3.76703085 |
| 24 | striated muscle contraction (GO:0006941) | 3.75657923 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75390385 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.72564057 |
| 27 | actomyosin structure organization (GO:0031032) | 3.69399277 |
| 28 | regulation of actin filament-based movement (GO:1903115) | 3.58215930 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 3.57019394 |
| 30 | relaxation of cardiac muscle (GO:0055119) | 3.51200929 |
| 31 | skeletal muscle adaptation (GO:0043501) | 3.50541712 |
| 32 | cell communication by electrical coupling (GO:0010644) | 3.50290762 |
| 33 | desmosome organization (GO:0002934) | 3.49428718 |
| 34 | keratinization (GO:0031424) | 3.49150806 |
| 35 | striated muscle hypertrophy (GO:0014897) | 3.48211884 |
| 36 | actin filament-based movement (GO:0030048) | 3.44054185 |
| 37 | detection of calcium ion (GO:0005513) | 3.41894188 |
| 38 | regulation of membrane repolarization (GO:0060306) | 3.41052144 |
| 39 | carnitine shuttle (GO:0006853) | 3.40957427 |
| 40 | interkinetic nuclear migration (GO:0022027) | 3.38801852 |
| 41 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.37439771 |
| 42 | positive regulation of cation channel activity (GO:2001259) | 3.34972870 |
| 43 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.32213984 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 3.31446612 |
| 45 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.27148876 |
| 46 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.27148876 |
| 47 | skeletal muscle contraction (GO:0003009) | 3.26829271 |
| 48 | cardiac conduction (GO:0061337) | 3.22466361 |
| 49 | cardiac muscle cell development (GO:0055013) | 3.22404923 |
| 50 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.21203243 |
| 51 | establishment of skin barrier (GO:0061436) | 3.19331300 |
| 52 | negative regulation of protein localization to cell surface (GO:2000009) | 3.17456712 |
| 53 | cardiac cell development (GO:0055006) | 3.06112903 |
| 54 | cardiac muscle cell action potential (GO:0086001) | 3.03975953 |
| 55 | muscle hypertrophy (GO:0014896) | 3.03816145 |
| 56 | hemidesmosome assembly (GO:0031581) | 3.02613212 |
| 57 | regulation of sarcomere organization (GO:0060297) | 3.00029290 |
| 58 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.94900542 |
| 59 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.94698432 |
| 60 | protein targeting to Golgi (GO:0000042) | 2.91895459 |
| 61 | striated muscle adaptation (GO:0014888) | 2.90859858 |
| 62 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.89035050 |
| 63 | fatty acid transmembrane transport (GO:1902001) | 2.86402707 |
| 64 | regulation of water loss via skin (GO:0033561) | 2.84501788 |
| 65 | striated muscle atrophy (GO:0014891) | 2.83092255 |
| 66 | adult heart development (GO:0007512) | 2.82863612 |
| 67 | regulation of cardiac muscle contraction (GO:0055117) | 2.82529377 |
| 68 | muscle contraction (GO:0006936) | 2.82129744 |
| 69 | membrane depolarization during action potential (GO:0086010) | 2.80532491 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.77207374 |
| 71 | establishment of protein localization to Golgi (GO:0072600) | 2.76605800 |
| 72 | cardiac muscle adaptation (GO:0014887) | 2.73621574 |
| 73 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.73621574 |
| 74 | muscle hypertrophy in response to stress (GO:0003299) | 2.73621574 |
| 75 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.71640484 |
| 76 | regulation of cation channel activity (GO:2001257) | 2.70727433 |
| 77 | carnitine transmembrane transport (GO:1902603) | 2.69726724 |
| 78 | regulation of the force of heart contraction (GO:0002026) | 2.68643488 |
| 79 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.66417736 |
| 80 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.65633957 |
| 81 | muscle system process (GO:0003012) | 2.65452896 |
| 82 | potassium ion import (GO:0010107) | 2.65430993 |
| 83 | relaxation of muscle (GO:0090075) | 2.63004905 |
| 84 | activation of protein kinase A activity (GO:0034199) | 2.61286997 |
| 85 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.59713672 |
| 86 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.58536874 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.57189615 |
| 88 | regulation of heart rate (GO:0002027) | 2.56735419 |
| 89 | response to inactivity (GO:0014854) | 2.56159268 |
| 90 | negative regulation of potassium ion transport (GO:0043267) | 2.55956405 |
| 91 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.55367753 |
| 92 | tricarboxylic acid cycle (GO:0006099) | 2.54246130 |
| 93 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.52072265 |
| 94 | import into cell (GO:0098657) | 2.51958320 |
| 95 | regulation of hippo signaling (GO:0035330) | 2.51455056 |
| 96 | oxygen transport (GO:0015671) | 2.49749789 |
| 97 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.48502298 |
| 98 | regulation of heart contraction (GO:0008016) | 2.48438371 |
| 99 | muscle tissue morphogenesis (GO:0060415) | 2.47919264 |
| 100 | muscle fiber development (GO:0048747) | 2.46740818 |
| 101 | myoblast fusion (GO:0007520) | 2.46620587 |
| 102 | regulation of p38MAPK cascade (GO:1900744) | 2.44634629 |
| 103 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.43860609 |
| 104 | nucleus localization (GO:0051647) | 2.42203277 |
| 105 | amino-acid betaine transport (GO:0015838) | 2.41968451 |
| 106 | carnitine transport (GO:0015879) | 2.41968451 |
| 107 | regulation of protein polyubiquitination (GO:1902914) | 2.41263534 |
| 108 | muscle atrophy (GO:0014889) | 2.39430134 |
| 109 | heart trabecula formation (GO:0060347) | 2.36173164 |
| 110 | positive regulation of fatty acid oxidation (GO:0046321) | 2.36052014 |
| 111 | positive regulation of heart contraction (GO:0045823) | 2.35990079 |
| 112 | muscle adaptation (GO:0043500) | 2.33751779 |
| 113 | regulation of synapse structural plasticity (GO:0051823) | 2.33596911 |
| 114 | response to muscle activity (GO:0014850) | 2.32594519 |
| 115 | growth hormone receptor signaling pathway (GO:0060396) | 2.32472265 |
| 116 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.28558662 |
| 117 | vesicle transport along microtubule (GO:0047496) | 2.27322963 |
| 118 | pericardium development (GO:0060039) | 2.26963028 |
| 119 | smooth muscle tissue development (GO:0048745) | 2.25435363 |
| 120 | keratinocyte proliferation (GO:0043616) | 2.24571148 |
| 121 | iron ion import (GO:0097286) | 2.21866584 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.20512524 |
| 123 | regulation of energy homeostasis (GO:2000505) | 2.19689808 |
| 124 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.15993283 |
| 125 | keratinocyte differentiation (GO:0030216) | 2.14342051 |
| 126 | peptide cross-linking (GO:0018149) | 2.13972622 |
| 127 | skeletal muscle fiber development (GO:0048741) | 2.13300147 |
| 128 | myotube cell development (GO:0014904) | 2.10909806 |
| 129 | skeletal muscle tissue development (GO:0007519) | 2.10148094 |
| 130 | regulation of sequestering of triglyceride (GO:0010889) | 2.09769513 |
| 131 | regulation of protein localization to cell surface (GO:2000008) | 2.08583595 |
| 132 | regulation of muscle adaptation (GO:0043502) | 2.06020290 |
| 133 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.05627743 |
| 134 | syncytium formation (GO:0006949) | 2.02419473 |
| 135 | lipid translocation (GO:0034204) | 2.01546454 |
| 136 | phospholipid translocation (GO:0045332) | 2.01546454 |
| 137 | cell-substrate junction assembly (GO:0007044) | 2.01540219 |
| 138 | cellular response to growth hormone stimulus (GO:0071378) | 2.01312727 |
| 139 | skin morphogenesis (GO:0043589) | 2.00801744 |
| 140 | early endosome to late endosome transport (GO:0045022) | 2.00379715 |
| 141 | negative regulation of systemic arterial blood pressure (GO:0003085) | 1.99947475 |
| 142 | multicellular organismal water homeostasis (GO:0050891) | 1.99414898 |
| 143 | skeletal muscle tissue regeneration (GO:0043403) | 1.99041033 |
| 144 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 1.98270548 |
| 145 | interleukin-6-mediated signaling pathway (GO:0070102) | 1.98257850 |
| 146 | metanephric mesenchyme development (GO:0072075) | 1.97282876 |
| 147 | positive regulation of p38MAPK cascade (GO:1900745) | 1.96836247 |
| 148 | regulation of cardiac muscle hypertrophy (GO:0010611) | 1.96025003 |
| 149 | protein localization to Golgi apparatus (GO:0034067) | 1.95877013 |
| 150 | myotube differentiation (GO:0014902) | 1.95826062 |
| 151 | regulation of sodium ion transmembrane transport (GO:1902305) | 1.94779792 |
| 152 | water homeostasis (GO:0030104) | 1.94616835 |
| 153 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.93656224 |
| 154 | chemical homeostasis within a tissue (GO:0048875) | 1.92893814 |
| 155 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 1.92679480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.39565642 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.26782624 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11725013 |
| 4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07055177 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.01221080 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.82873035 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.71668216 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.71349844 |
| 9 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66454202 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61975633 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61673790 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60406356 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.59012266 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.59012266 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57356167 |
| 16 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56571335 |
| 17 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56571335 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.56071076 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52305673 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.51408384 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49597979 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48473679 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47672423 |
| 24 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47007722 |
| 25 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44942806 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43194956 |
| 27 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42752756 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41443117 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38402102 |
| 30 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.37238464 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36985672 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35662865 |
| 33 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34374017 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34372198 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.33057108 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31750531 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.30304997 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27866716 |
| 39 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25978459 |
| 40 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.25298900 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25198766 |
| 42 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24955436 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22985812 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22312578 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21314642 |
| 46 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21021309 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20493095 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20254678 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19721977 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18996503 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17760045 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17638987 |
| 53 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16821381 |
| 54 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16344610 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15713617 |
| 56 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14283548 |
| 57 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14154265 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14069565 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13917551 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13893339 |
| 61 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13872782 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13732455 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12671991 |
| 64 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10665984 |
| 65 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10665984 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09642993 |
| 67 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09001906 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08780170 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.07070536 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06445536 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06345092 |
| 72 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.06271046 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04669050 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04458002 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04118717 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03940464 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03384848 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02436217 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02362361 |
| 80 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02202460 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01376494 |
| 82 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00496706 |
| 83 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99711204 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99438987 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99405617 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99159403 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98885749 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98303814 |
| 89 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97717288 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97508816 |
| 91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97437327 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97197854 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96398719 |
| 94 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96265368 |
| 95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95511595 |
| 96 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95353125 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95213391 |
| 98 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94584870 |
| 99 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94347511 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94206227 |
| 101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93835426 |
| 102 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93761990 |
| 103 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92781394 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92717835 |
| 105 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92539434 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92438093 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92196565 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91977182 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91956251 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91956251 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91191443 |
| 112 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90686704 |
| 113 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90534356 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89672247 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89581077 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89565373 |
| 117 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89534454 |
| 118 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89418069 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89332328 |
| 120 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88941030 |
| 121 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87395348 |
| 122 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87159648 |
| 123 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86375259 |
| 124 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85358553 |
| 125 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85358553 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85148187 |
| 127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84966268 |
| 128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84550502 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83827858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.43462749 |
| 2 | MP0000751_myopathy | 4.87341079 |
| 3 | MP0003646_muscle_fatigue | 4.62672474 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.79286352 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.73773857 |
| 6 | MP0000749_muscle_degeneration | 3.69578648 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.52309591 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.31319191 |
| 9 | MP0004087_abnormal_muscle_fiber | 2.80721749 |
| 10 | MP0004130_abnormal_muscle_cell | 2.79186158 |
| 11 | MP0004510_myositis | 2.68995760 |
| 12 | MP0005330_cardiomyopathy | 2.60410615 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.51112559 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.48881409 |
| 15 | MP0000383_abnormal_hair_follicle | 2.44156467 |
| 16 | MP0004484_altered_response_of | 2.37225155 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.30631674 |
| 18 | MP0002972_abnormal_cardiac_muscle | 2.27501751 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.12242646 |
| 20 | MP0005369_muscle_phenotype | 2.06996620 |
| 21 | MP0000759_abnormal_skeletal_muscle | 2.04356805 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.02704492 |
| 23 | MP0002269_muscular_atrophy | 1.98660642 |
| 24 | MP0010630_abnormal_cardiac_muscle | 1.94491688 |
| 25 | MP0000747_muscle_weakness | 1.93695793 |
| 26 | MP0010678_abnormal_skin_adnexa | 1.87915887 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.85850599 |
| 28 | MP0004233_abnormal_muscle_weight | 1.84845332 |
| 29 | MP0003828_pulmonary_edema | 1.79981946 |
| 30 | MP0003045_fibrosis | 1.77279561 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.76453701 |
| 32 | MP0001544_abnormal_cardiovascular_syste | 1.76453701 |
| 33 | MP0004085_abnormal_heartbeat | 1.76156975 |
| 34 | MP0004043_abnormal_pH_regulation | 1.71968189 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.70652385 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.67436869 |
| 37 | MP0005275_abnormal_skin_tensile | 1.66323857 |
| 38 | MP0001958_emphysema | 1.62395318 |
| 39 | MP0006138_congestive_heart_failure | 1.57580964 |
| 40 | MP0005670_abnormal_white_adipose | 1.55842141 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.53768689 |
| 42 | MP0000427_abnormal_hair_cycle | 1.49929498 |
| 43 | MP0005409_darkened_coat_color | 1.47532083 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.46615676 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.42478673 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.41577383 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.36083766 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.34245905 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.32004828 |
| 50 | MP0003635_abnormal_synaptic_transmissio | 1.26204854 |
| 51 | MP0009046_muscle_twitch | 1.21201355 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.20615392 |
| 53 | MP0005023_abnormal_wound_healing | 1.20210590 |
| 54 | MP0005375_adipose_tissue_phenotype | 1.19363330 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.19043997 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.15493090 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.09080001 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.08159985 |
| 59 | MP0000733_abnormal_muscle_development | 1.05785934 |
| 60 | MP0008569_lethality_at_weaning | 1.04383308 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.02541942 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.02371993 |
| 63 | MP0004885_abnormal_endolymph | 1.00784778 |
| 64 | MP0002060_abnormal_skin_morphology | 0.98549419 |
| 65 | MP0005595_abnormal_vascular_smooth | 0.98024202 |
| 66 | MP0003950_abnormal_plasma_membrane | 0.97669942 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.97618636 |
| 68 | MP0010368_abnormal_lymphatic_system | 0.96587730 |
| 69 | MP0002168_other_aberrant_phenotype | 0.95945458 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95813122 |
| 71 | MP0004134_abnormal_chest_morphology | 0.94940571 |
| 72 | MP0000003_abnormal_adipose_tissue | 0.94327510 |
| 73 | MP0005451_abnormal_body_composition | 0.91527490 |
| 74 | MP0001299_abnormal_eye_distance/ | 0.88486135 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 0.88455758 |
| 76 | MP0002063_abnormal_learning/memory/cond | 0.87729245 |
| 77 | MP0004270_analgesia | 0.87340684 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.86233851 |
| 79 | MP0000266_abnormal_heart_morphology | 0.85558651 |
| 80 | MP0009745_abnormal_behavioral_response | 0.84836767 |
| 81 | MP0002971_abnormal_brown_adipose | 0.84392906 |
| 82 | MP0000467_abnormal_esophagus_morphology | 0.83379424 |
| 83 | MP0003787_abnormal_imprinting | 0.83171390 |
| 84 | MP0002796_impaired_skin_barrier | 0.81582018 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.81211305 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.79741448 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.79516593 |
| 88 | MP0003279_aneurysm | 0.78625862 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.78093834 |
| 90 | MP0005266_abnormal_metabolism | 0.77394911 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.76332401 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.75010399 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 0.74930200 |
| 94 | MP0002009_preneoplasia | 0.74425612 |
| 95 | MP0010771_integument_phenotype | 0.73846502 |
| 96 | MP0000579_abnormal_nail_morphology | 0.73396463 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.73368447 |
| 98 | MP0009115_abnormal_fat_cell | 0.72677672 |
| 99 | MP0003195_calcinosis | 0.72433941 |
| 100 | MP0003941_abnormal_skin_development | 0.72056072 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.70687291 |
| 102 | MP0005501_abnormal_skin_physiology | 0.69813738 |
| 103 | MP0005187_abnormal_penis_morphology | 0.69016964 |
| 104 | MP0005165_increased_susceptibility_to | 0.68855977 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.68634685 |
| 106 | MP0000762_abnormal_tongue_morphology | 0.67973890 |
| 107 | MP0001440_abnormal_grooming_behavior | 0.67398273 |
| 108 | MP0002822_catalepsy | 0.66847538 |
| 109 | MP0002064_seizures | 0.66377140 |
| 110 | MP0001502_abnormal_circadian_rhythm | 0.66368770 |
| 111 | MP0004947_skin_inflammation | 0.66140168 |
| 112 | MP0001542_abnormal_bone_strength | 0.65542987 |
| 113 | MP0005164_abnormal_response_to | 0.64371216 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.62320719 |
| 115 | MP0002166_altered_tumor_susceptibility | 0.60662648 |
| 116 | MP0001501_abnormal_sleep_pattern | 0.58145101 |
| 117 | MP0002128_abnormal_blood_circulation | 0.57910875 |
| 118 | MP0003091_abnormal_cell_migration | 0.57375877 |
| 119 | MP0002572_abnormal_emotion/affect_behav | 0.56560512 |
| 120 | MP0000343_altered_response_to | 0.56283676 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.55834798 |
| 122 | MP0002735_abnormal_chemical_nociception | 0.55690534 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.55357693 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.52979895 |
| 125 | MP0008438_abnormal_cutaneous_collagen | 0.52807448 |
| 126 | MP0004924_abnormal_behavior | 0.52315044 |
| 127 | MP0005386_behavior/neurological_phenoty | 0.52315044 |
| 128 | MP0003879_abnormal_hair_cell | 0.50998977 |
| 129 | MP0003633_abnormal_nervous_system | 0.49411430 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.49384032 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.48782730 |
| 132 | MP0008004_abnormal_stomach_pH | 0.48304200 |
| 133 | MP0005535_abnormal_body_temperature | 0.47248022 |
| 134 | MP0001486_abnormal_startle_reflex | 0.46915964 |
| 135 | MP0005334_abnormal_fat_pad | 0.45810963 |
| 136 | MP0004272_abnormal_basement_membrane | 0.44983568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.35762704 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.15264759 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.55617264 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.47090100 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 5.15669379 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 5.06160902 |
| 7 | Ventricular tachycardia (HP:0004756) | 4.90956489 |
| 8 | Muscle fiber splitting (HP:0003555) | 4.84912219 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 4.79766932 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 4.79457456 |
| 11 | Atrial fibrillation (HP:0005110) | 4.62893876 |
| 12 | Difficulty running (HP:0009046) | 4.43295371 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 4.38534450 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 4.20401206 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.11419064 |
| 16 | Subaortic stenosis (HP:0001682) | 4.10389293 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.10389293 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.10100268 |
| 19 | Increased connective tissue (HP:0009025) | 4.09687894 |
| 20 | Bundle branch block (HP:0011710) | 4.07565449 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.02141566 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.98747323 |
| 23 | Syncope (HP:0001279) | 3.93637676 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.89197126 |
| 25 | Myoglobinuria (HP:0002913) | 3.59245425 |
| 26 | Prolonged QT interval (HP:0001657) | 3.57090690 |
| 27 | Lipoatrophy (HP:0100578) | 3.53105485 |
| 28 | Myotonia (HP:0002486) | 3.44805291 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.41922680 |
| 30 | Nemaline bodies (HP:0003798) | 3.35912641 |
| 31 | Ventricular fibrillation (HP:0001663) | 3.25531823 |
| 32 | Ventricular arrhythmia (HP:0004308) | 3.21461839 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.14882039 |
| 34 | Dysmetric saccades (HP:0000641) | 2.99030827 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.93990970 |
| 36 | Lip pit (HP:0100267) | 2.90772955 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.90459461 |
| 38 | Heart block (HP:0012722) | 2.86610628 |
| 39 | Dilated cardiomyopathy (HP:0001644) | 2.84282674 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.82029797 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 2.80788764 |
| 42 | Abnormal EKG (HP:0003115) | 2.77857180 |
| 43 | Lower limb amyotrophy (HP:0007210) | 2.64442807 |
| 44 | Facial diplegia (HP:0001349) | 2.61465960 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.57341558 |
| 46 | Fair hair (HP:0002286) | 2.56814731 |
| 47 | Frequent falls (HP:0002359) | 2.50386149 |
| 48 | Muscle stiffness (HP:0003552) | 2.49665480 |
| 49 | Hyperkalemia (HP:0002153) | 2.48764090 |
| 50 | Atrioventricular block (HP:0001678) | 2.45391140 |
| 51 | Neck muscle weakness (HP:0000467) | 2.43280581 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41662362 |
| 53 | Hypoplastic ischia (HP:0003175) | 2.39884544 |
| 54 | Abnormality of secondary sexual hair (HP:0009888) | 2.38577587 |
| 55 | Abnormality of the axillary hair (HP:0100134) | 2.38577587 |
| 56 | Distal arthrogryposis (HP:0005684) | 2.38510253 |
| 57 | Round ear (HP:0100830) | 2.37105780 |
| 58 | Left ventricular hypertrophy (HP:0001712) | 2.31460641 |
| 59 | Proximal amyotrophy (HP:0007126) | 2.30712531 |
| 60 | Rhabdomyolysis (HP:0003201) | 2.29732478 |
| 61 | Scapular winging (HP:0003691) | 2.28192635 |
| 62 | Abnormality of nail color (HP:0100643) | 2.27521472 |
| 63 | Generalized hypopigmentation of hair (HP:0011358) | 2.26474918 |
| 64 | Myopathic facies (HP:0002058) | 2.25402749 |
| 65 | Palpitations (HP:0001962) | 2.25265269 |
| 66 | Alopecia of scalp (HP:0002293) | 2.23465609 |
| 67 | Areflexia of lower limbs (HP:0002522) | 2.20228326 |
| 68 | Muscular dystrophy (HP:0003560) | 2.19311298 |
| 69 | Hyperventilation (HP:0002883) | 2.19121428 |
| 70 | EMG: neuropathic changes (HP:0003445) | 2.17934746 |
| 71 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.16918736 |
| 72 | Limited hip movement (HP:0008800) | 2.16764664 |
| 73 | Limb-girdle muscle atrophy (HP:0003797) | 2.08920553 |
| 74 | Focal motor seizures (HP:0011153) | 2.08586489 |
| 75 | Abnormality of the ischium (HP:0003174) | 2.07306612 |
| 76 | Fatigable weakness (HP:0003473) | 2.02507338 |
| 77 | Abnormality of the neuromuscular junction (HP:0003398) | 2.02507338 |
| 78 | Thick nail (HP:0001805) | 1.99381790 |
| 79 | Rimmed vacuoles (HP:0003805) | 1.98861210 |
| 80 | Gowers sign (HP:0003391) | 1.98135698 |
| 81 | Genetic anticipation (HP:0003743) | 1.97711527 |
| 82 | Broad metatarsal (HP:0001783) | 1.97383694 |
| 83 | Arterial tortuosity (HP:0005116) | 1.96624075 |
| 84 | Ulnar deviation of the wrist (HP:0003049) | 1.94456793 |
| 85 | Cerebral aneurysm (HP:0004944) | 1.94204851 |
| 86 | Sudden cardiac death (HP:0001645) | 1.91771424 |
| 87 | Widely spaced teeth (HP:0000687) | 1.91657807 |
| 88 | Palmoplantar hyperkeratosis (HP:0000972) | 1.91475663 |
| 89 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90928821 |
| 90 | Vascular tortuosity (HP:0004948) | 1.90230108 |
| 91 | Cardiovascular calcification (HP:0011915) | 1.86625524 |
| 92 | Oligodontia (HP:0000677) | 1.85795539 |
| 93 | Focal seizures (HP:0007359) | 1.85076958 |
| 94 | Hypoplasia of the iris (HP:0007676) | 1.84263873 |
| 95 | Aortic dissection (HP:0002647) | 1.83869979 |
| 96 | Plantar hyperkeratosis (HP:0007556) | 1.81674959 |
| 97 | Blue irides (HP:0000635) | 1.80288981 |
| 98 | Clumsiness (HP:0002312) | 1.80070866 |
| 99 | Overgrowth (HP:0001548) | 1.79231647 |
| 100 | Palmoplantar keratoderma (HP:0000982) | 1.78481483 |
| 101 | Abnormality of the labia majora (HP:0012881) | 1.77522065 |
| 102 | Hypoplastic labia majora (HP:0000059) | 1.77517166 |
| 103 | Generalized muscle weakness (HP:0003324) | 1.76717319 |
| 104 | Bradycardia (HP:0001662) | 1.73926960 |
| 105 | Absent phalangeal crease (HP:0006109) | 1.73662745 |
| 106 | Palmar hyperkeratosis (HP:0010765) | 1.73368457 |
| 107 | Gaze-evoked nystagmus (HP:0000640) | 1.73113532 |
| 108 | Spinal rigidity (HP:0003306) | 1.72768096 |
| 109 | Hamartoma of the eye (HP:0010568) | 1.71555019 |
| 110 | Milia (HP:0001056) | 1.71469733 |
| 111 | Protruding tongue (HP:0010808) | 1.70973765 |
| 112 | Corneal erosion (HP:0200020) | 1.70396899 |
| 113 | Hip contracture (HP:0003273) | 1.69267947 |
| 114 | Follicular hyperkeratosis (HP:0007502) | 1.68548021 |
| 115 | Febrile seizures (HP:0002373) | 1.68375558 |
| 116 | Hyperglycemia (HP:0003074) | 1.66959766 |
| 117 | Abnormality of potassium homeostasis (HP:0011042) | 1.66200585 |
| 118 | Atrophic scars (HP:0001075) | 1.65212919 |
| 119 | Progressive cerebellar ataxia (HP:0002073) | 1.65094701 |
| 120 | Broad-based gait (HP:0002136) | 1.64959930 |
| 121 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.63822447 |
| 122 | Tibial bowing (HP:0002982) | 1.63463748 |
| 123 | Limb-girdle muscle weakness (HP:0003325) | 1.63317534 |
| 124 | Visual hallucinations (HP:0002367) | 1.62960461 |
| 125 | Vascular calcification (HP:0004934) | 1.62102753 |
| 126 | Rapidly progressive (HP:0003678) | 1.62039017 |
| 127 | Congestive heart failure (HP:0001635) | 1.61873610 |
| 128 | Testicular atrophy (HP:0000029) | 1.61059519 |
| 129 | Atonic seizures (HP:0010819) | 1.60495949 |
| 130 | Truncal obesity (HP:0001956) | 1.60210876 |
| 131 | Abnormality of the nasal septum (HP:0000419) | 1.59969514 |
| 132 | Central scotoma (HP:0000603) | 1.59165551 |
| 133 | Aneurysm (HP:0002617) | 1.58751722 |
| 134 | Malignant hyperthermia (HP:0002047) | 1.58371773 |
| 135 | Hypotrichosis (HP:0001006) | 1.57957693 |
| 136 | Toxemia of pregnancy (HP:0100603) | 1.56850064 |
| 137 | Bulbar palsy (HP:0001283) | 1.55625788 |
| 138 | Ketoacidosis (HP:0001993) | 1.55110850 |
| 139 | Aortic aneurysm (HP:0004942) | 1.46770747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.70622726 |
| 2 | OBSCN | 4.00558142 |
| 3 | DMPK | 3.14906411 |
| 4 | PHKG2 | 3.08842012 |
| 5 | PHKG1 | 3.08842012 |
| 6 | AKT3 | 2.69524576 |
| 7 | PDK4 | 2.54487418 |
| 8 | PDK3 | 2.54487418 |
| 9 | LMTK2 | 2.18757855 |
| 10 | TRIB3 | 1.96755837 |
| 11 | RIPK1 | 1.79613764 |
| 12 | INSRR | 1.76537364 |
| 13 | PIK3CA | 1.75122078 |
| 14 | MAP3K7 | 1.69136042 |
| 15 | MST1R | 1.60382138 |
| 16 | PDK2 | 1.53665181 |
| 17 | NTRK3 | 1.50611266 |
| 18 | STK38 | 1.50032406 |
| 19 | MET | 1.47750761 |
| 20 | CAMK1G | 1.47203263 |
| 21 | MAP3K4 | 1.41839997 |
| 22 | PKN2 | 1.39619843 |
| 23 | MAP2K4 | 1.35278526 |
| 24 | PRKD3 | 1.32578427 |
| 25 | BMPR1B | 1.30175327 |
| 26 | MYLK | 1.26677347 |
| 27 | LATS1 | 1.13603080 |
| 28 | SGK3 | 1.11278472 |
| 29 | TAOK3 | 1.10992342 |
| 30 | FER | 1.08595437 |
| 31 | JAK1 | 1.07243432 |
| 32 | MUSK | 1.06698335 |
| 33 | DDR2 | 1.05883091 |
| 34 | PTK2B | 1.05326049 |
| 35 | STK24 | 1.03869634 |
| 36 | PIK3CG | 1.01927701 |
| 37 | SGK2 | 1.01652197 |
| 38 | CDC42BPA | 1.00362950 |
| 39 | CAMK1D | 0.98265023 |
| 40 | TRPM7 | 0.98075090 |
| 41 | MAPK12 | 0.97785055 |
| 42 | TIE1 | 0.97558534 |
| 43 | PINK1 | 0.97326219 |
| 44 | ADRBK2 | 0.96471685 |
| 45 | EPHA2 | 0.94912373 |
| 46 | MAP3K2 | 0.92912768 |
| 47 | EPHA4 | 0.92568542 |
| 48 | PDGFRA | 0.92545087 |
| 49 | MAPK7 | 0.92175087 |
| 50 | ACVR1B | 0.91827311 |
| 51 | PTK6 | 0.89557764 |
| 52 | MAPK15 | 0.89483767 |
| 53 | PNCK | 0.89113046 |
| 54 | MAP3K9 | 0.87977898 |
| 55 | PRKCH | 0.87464959 |
| 56 | PRKAA2 | 0.86965497 |
| 57 | STK39 | 0.86815667 |
| 58 | MAP2K3 | 0.86288191 |
| 59 | ADRBK1 | 0.85204823 |
| 60 | TGFBR2 | 0.84717880 |
| 61 | CAMK4 | 0.82834167 |
| 62 | PAK3 | 0.82287079 |
| 63 | DAPK2 | 0.82161537 |
| 64 | FGFR3 | 0.81631517 |
| 65 | TGFBR1 | 0.81171246 |
| 66 | NME1 | 0.80954227 |
| 67 | RIPK4 | 0.80489522 |
| 68 | MARK1 | 0.80122647 |
| 69 | PRKD1 | 0.79946209 |
| 70 | WNK1 | 0.79330424 |
| 71 | SIK2 | 0.79281852 |
| 72 | MTOR | 0.79245677 |
| 73 | LATS2 | 0.79219091 |
| 74 | CAMK1 | 0.78966085 |
| 75 | PTK2 | 0.77179130 |
| 76 | SGK1 | 0.77171252 |
| 77 | PRKAA1 | 0.73314298 |
| 78 | ROCK1 | 0.73153621 |
| 79 | CAMKK2 | 0.72849687 |
| 80 | FRK | 0.72550408 |
| 81 | CAMK2D | 0.72278445 |
| 82 | GRK7 | 0.71857369 |
| 83 | MAP2K1 | 0.71542203 |
| 84 | MAP3K5 | 0.70500262 |
| 85 | PDK1 | 0.70245786 |
| 86 | CAMKK1 | 0.68932937 |
| 87 | CAMK2A | 0.64470563 |
| 88 | CHUK | 0.64313685 |
| 89 | ZAK | 0.64111144 |
| 90 | STK11 | 0.63147893 |
| 91 | RET | 0.63056701 |
| 92 | MARK2 | 0.63035721 |
| 93 | PDPK1 | 0.61953071 |
| 94 | SIK1 | 0.60973669 |
| 95 | PRKD2 | 0.59460794 |
| 96 | CDK12 | 0.59451213 |
| 97 | CAMK2G | 0.59002645 |
| 98 | NEK9 | 0.57270892 |
| 99 | TAOK1 | 0.55805544 |
| 100 | PAK6 | 0.55791078 |
| 101 | EPHB2 | 0.55764887 |
| 102 | PRKCE | 0.54618830 |
| 103 | PDGFRB | 0.53806292 |
| 104 | STK3 | 0.53727843 |
| 105 | ICK | 0.53433098 |
| 106 | STK38L | 0.51782937 |
| 107 | CAMK2B | 0.51742910 |
| 108 | MAP3K13 | 0.51362221 |
| 109 | EEF2K | 0.49990415 |
| 110 | NTRK2 | 0.49496893 |
| 111 | MELK | 0.49427900 |
| 112 | MAP2K7 | 0.49113766 |
| 113 | PLK2 | 0.48245871 |
| 114 | PAK2 | 0.47478056 |
| 115 | SGK494 | 0.45924981 |
| 116 | SGK223 | 0.45924981 |
| 117 | WNK4 | 0.45666833 |
| 118 | NLK | 0.45637387 |
| 119 | RPS6KA6 | 0.44813437 |
| 120 | CDK5 | 0.44434103 |
| 121 | ERBB3 | 0.43450406 |
| 122 | MINK1 | 0.42672621 |
| 123 | ABL2 | 0.42297990 |
| 124 | RPS6KA3 | 0.41928056 |
| 125 | MAP2K6 | 0.41121398 |
| 126 | EPHA3 | 0.40408219 |
| 127 | MAP3K6 | 0.39740000 |
| 128 | PRKG1 | 0.39601164 |
| 129 | MAP3K3 | 0.38165153 |
| 130 | MAPKAPK3 | 0.36995018 |
| 131 | RPS6KA2 | 0.36511200 |
| 132 | NEK1 | 0.36072522 |
| 133 | PRKACB | 0.34427337 |
| 134 | MAP3K1 | 0.33009715 |
| 135 | EPHB1 | 0.32432605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.88217406 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.74437020 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.40261957 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.17153400 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.01837059 |
| 6 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90198680 |
| 7 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66164394 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64232095 |
| 9 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.63451990 |
| 10 | Renin secretion_Homo sapiens_hsa04924 | 1.61551833 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58425429 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.56228100 |
| 13 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56147226 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52854780 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.52296077 |
| 16 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.50193336 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48671543 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.47141240 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39922016 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39313805 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.38248724 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.35845289 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.34544650 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34437372 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29815562 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.26616546 |
| 27 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23062421 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21355566 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.19657481 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.19240318 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.18104636 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17902455 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.17472349 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16715834 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.16584437 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15568882 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13439724 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.12446249 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09665217 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.06873272 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06203408 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05503595 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04578141 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03448021 |
| 45 | GABAergic synapse_Homo sapiens_hsa04727 | 1.01108249 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99592423 |
| 47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.99042363 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.97227973 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97082690 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 0.95553341 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93637902 |
| 52 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90153810 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89307135 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88061759 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 0.87497200 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.86433206 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86181007 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85266295 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78435581 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77265221 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76651861 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76539152 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76037935 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75060443 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.74840035 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.73299888 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72179465 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71854964 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71534757 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.71504318 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.70863832 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69324479 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68694667 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68455827 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68299962 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67798917 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.67460407 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65462242 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65342386 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64831805 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64365890 |
| 82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64172978 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63666262 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63033604 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62574310 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.62064977 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.61482810 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61240166 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.61170951 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61073906 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59838183 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59605901 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58854225 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57903213 |
| 95 | Melanoma_Homo sapiens_hsa05218 | 0.57420662 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57038535 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56769790 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56705129 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56491204 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56256620 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56064774 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55887202 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55656360 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54703406 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.54422232 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.54377515 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53406983 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53327347 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53148150 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52351141 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52048172 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51622669 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50487946 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50312931 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50213448 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50136854 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49476312 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49298919 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48586006 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48156223 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46487967 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46091973 |
| 123 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44733331 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44581373 |
| 125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43105569 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42260987 |
| 127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39550047 |

